Approval · Notice of Compliance 13039 · 2012
ZELBORAF: Notice of Compliance 13039
Issued February 15, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13039
- Date
- February 15, 2012
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Protein Kinase Inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZELBORAF | 02380242 | Marketed |
Medicinal ingredients
- VEMURAFENIB 240 MG per TAB